|Day Low/High||91.59 / 91.70|
|52 Wk Low/High||44.00 / 69.48|
Companies developing drugs for cancer, eye problems and pets -- offer untapped value.
In a promising development for pet cancer patients in the Northeast, Animal Specialty Center (ASC) introduced its new TrueBeam™ Radiotherapy system to leading veterinary professionals with a formal ribbon cutting...
These stocks are showing short-term gain catalysts and longer-term growth potential. Here's how to trade them.
Cramer shares his views on the pajama traders, and talks turkey about pet stocks.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased VCA Inc.
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of VCA Inc.
Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of VCA Inc.
Animal health and oncology deal activity is heating up in 2017.
Cramer can't understand why shares of Johnson Controls spinoff Adient aren't trading higher.
This year's profitable trends look to persist into 2017.
Going into earnings what the market needs now is more negativity, Cramer says.
McDonald's announces its intentions to sell its China business to a group including Carlyle Group as Apple celebrates the iPhone's 10th birthday. Plus Trump's latest meetings.
A selloff in crude oil proves another roadblock in the Dow Jones Industrial Average's pursuit of 20,000.
The Mars-VCA deal is yet another sign that pet health is a robust business.
Put a charge in your portfolio this week.
Rigrodsky & Long, P.A.
Stocks trade mostly lower with the Dow Jones Industrial Average taking a pause in its race toward 20,000.
Mars is making moves in 'one of the fastest growing secular stories in the world' with its acquisition of VCA, TheStreet's Jim Cramer said.
Jim Cramer says the deal between Mars and VCA is another example of how pet pampering is becoming big business.